title: PRASFIT-ACS: important evidence against a "one-guideline-fits-all-races" approach to antiplatelet therapy.
authors.affiliation: Division of Cardiology, Gyeongsang National University Hospital and Gyeongsang National University School of Medicine.
authors.forename: Jong-Hwa
authors.initials: JH
authors.lastname: Ahn
authors.forename: Udaya S
authors.initials: US
authors.lastname: Tantry
authors.forename: Kye-Hwan
authors.initials: KH
authors.lastname: Kim
authors.forename: Paul
authors.initials: P
authors.lastname: Gurbel
authors.forename: Young-Hoon
authors.initials: YH
authors.lastname: Jeong
mesh_terms: D001241:Aspirin; D006801:Humans; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D013988:Ticlopidine; D001241:Aspirin